532 related articles for article (PubMed ID: 21721011)
21. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
[TBL] [Abstract][Full Text] [Related]
22. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
[TBL] [Abstract][Full Text] [Related]
23. Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer.
Cooper WA; Kohonen-Corish MR; McCaughan B; Kennedy C; Sutherland RL; Lee CS
Histopathology; 2009 Jul; 55(1):28-36. PubMed ID: 19614764
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of MAD2 predicts clinical outcome in primary lung cancer patients.
Kato T; Daigo Y; Aragaki M; Ishikawa K; Sato M; Kondo S; Kaji M
Lung Cancer; 2011 Oct; 74(1):124-31. PubMed ID: 21376419
[TBL] [Abstract][Full Text] [Related]
26. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
[TBL] [Abstract][Full Text] [Related]
27. Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features.
Capodanno A; Boldrini L; Proietti A; Alì G; Pelliccioni S; Niccoli C; D'Incecco A; Cappuzzo F; Chella A; Lucchi M; Mussi A; Fontanini G
Int J Oncol; 2013 Sep; 43(3):765-74. PubMed ID: 23820752
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer.
Chang YS; Kong G; Sun S; Liu D; El-Naggar AK; Khuri FR; Hong WK; Lee HY
Clin Cancer Res; 2002 Dec; 8(12):3796-802. PubMed ID: 12473592
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer.
Raponi M; Dossey L; Jatkoe T; Wu X; Chen G; Fan H; Beer DG
Cancer Res; 2009 Jul; 69(14):5776-83. PubMed ID: 19584273
[TBL] [Abstract][Full Text] [Related]
30. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
Tsai MF; Wang CC; Chang GC; Chen CY; Chen HY; Cheng CL; Yang YP; Wu CY; Shih FY; Liu CC; Lin HP; Jou YS; Lin SC; Lin CW; Chen WJ; Chan WK; Chen JJ; Yang PC
J Natl Cancer Inst; 2006 Jun; 98(12):825-38. PubMed ID: 16788156
[TBL] [Abstract][Full Text] [Related]
31. Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting.
Wu DW; Cheng YW; Wang J; Chen CY; Lee H
Cancer Res; 2010 Dec; 70(24):10392-401. PubMed ID: 21159652
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of miR-125a-5p and let-7e predicts the progression and prognosis of non-small cell lung cancer.
Zhu WY; Luo B; An JY; He JY; Chen DD; Xu LY; Huang YY; Liu XG; Le HB; Zhang YK
Cancer Invest; 2014 Oct; 32(8):394-401. PubMed ID: 24945821
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of microRNA-124 is correlated with tumor metastasis and poor prognosis in patients with lung cancer.
Zhang Y; Li H; Han J; Zhang Y
Int J Clin Exp Pathol; 2015; 8(2):1967-72. PubMed ID: 25973090
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of RIN1 gene expression in human non-small cell lung cancer.
Wang Q; Gao Y; Tang Y; Ma L; Zhao M; Wang X
Acta Histochem; 2012 Sep; 114(5):463-8. PubMed ID: 21925717
[TBL] [Abstract][Full Text] [Related]
35. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
Zhang Z; Ma J; Li N; Sun N; Wang C
Ann Thorac Surg; 2006 Jul; 82(1):243-8. PubMed ID: 16798222
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers.
Lu C; Soria JC; Tang X; Xu XC; Wang L; Mao L; Lotan R; Kemp B; Bekele BN; Feng L; Hong WK; Khuri FR
J Clin Oncol; 2004 Nov; 22(22):4575-83. PubMed ID: 15542809
[TBL] [Abstract][Full Text] [Related]
37. Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05).
Joerger M; Baty F; Früh M; Droege C; Stahel RA; Betticher DC; von Moos R; Ochsenbein A; Pless M; Gautschi O; Rothschild S; Brauchli P; Klingbiel D; Zappa F; Brutsche M
Lung Cancer; 2014 Aug; 85(2):306-13. PubMed ID: 24928469
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of reversion-inducing cysteine-rich protein with Kazal motifs expression in resected pathologic stage IIIA N2 non-small-cell lung cancer.
Takenaka K; Ishikawa S; Yanagihara K; Miyahara R; Hasegawa S; Otake Y; Morioka Y; Takahashi C; Noda M; Ito H; Wada H; Tanaka F
Ann Surg Oncol; 2005 Oct; 12(10):817-24. PubMed ID: 16132376
[TBL] [Abstract][Full Text] [Related]
39. hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer.
Wang L; Soria JC; Kemp BL; Liu DD; Mao L; Khuri FR
Clin Cancer Res; 2002 Sep; 8(9):2883-9. PubMed ID: 12231532
[TBL] [Abstract][Full Text] [Related]
40. Validating the prognostic value of marker genes derived from a non-small cell lung cancer microarray study.
Blackhall FH; Wigle DA; Jurisica I; Pintilie M; Liu N; Darling G; Johnston MR; Keshavjee S; Waddell T; Winton T; Shepherd FA; Tsao MS
Lung Cancer; 2004 Nov; 46(2):197-204. PubMed ID: 15474668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]